Back to search

Article

Dexmedetomidine is a safe and useful palliative sedative for refractory dyspnoea in patients with terminal-stage cancer

2022-12-14

Abstract excerpt

<h4>Background: </h4> Dyspnoea affects a considerable percentage of patients with terminal-stage cancer, and clinical guidelines recommend palliative sedation for patients with refractory dyspnoea, which cannot be alleviated with current therapies. Midazolam is currently the most commonly used sedative; however, it can cause serious adverse reactions, such as respiratory/circulatory depression. Hence, there is a n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb71ed3f-71ae-5f67-b271-b9053dd61f93
DOI
10.21203/rs.3.rs-2362027/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dexmedetomidine is a safe and useful palliative sedative for refractory dyspnoea in patients with terminal-stage cancerDOI 10.21203/rs.3.rs-2362027/v1
Select a neighboring publication to make it the new centre.